Chronic mucocutaneous candidiasis as a nosological form of primary immunodeficiency in children: the case of mucocutaneous candidiasis in a young child

Authors

  • О.G. Shadrin SI «Institute of Pediatrics, Obstetrics and Gynecology named of academician O.M. Lukyanova NAMS of Ukraine», Ukraine
  • L.І. Chernishova SI «Institute of Pediatrics, Obstetrics and Gynecology named of academician O.M. Lukyanova NAMS of Ukraine», Ukraine
  • V.V. Zaets SI «Institute of Pediatrics, Obstetrics and Gynecology named of academician O.M. Lukyanova NAMS of Ukraine», Ukraine
  • V.М. Fisun SI «Institute of Pediatrics, Obstetrics and Gynecology named of academician O.M. Lukyanova NAMS of Ukraine», Ukraine
  • N.G. Chumachenko SI «Institute of Pediatrics, Obstetrics and Gynecology named of academician O.M. Lukyanova NAMS of Ukraine», Ukraine

DOI:

https://doi.org/10.15574/PP.2020.82.98

Keywords:

immunodeficiency, chronic mucocutaneous, children

Abstract

Chronic mucocutaneus candidiasis or chronic generalized candidiasis is a primary combined immunodeficiency characterized by persistence of a mucocutaneous fungal infection caused by Candida fungi and is often manifested in children. Modes of its inheritance are autosomal recessive and autosomal dominant with rare sporadic cases. This article contains a clinical case of a chronic mucocutaneus candidiasis in a toddler caused by a gene mutation STATI (GOF).

It has been established that vigilance of doctors regarding clinical and immunological markers of primary immunodeficiency improves early diagnosis and promotes timely adequate therapy, prevents severe and irreversible disorders. And this, in turn, significantly improves the quality of life of patients and the further prognosis of primary immunodeficiency disorders.

 

References

Blagotvoritelnyiy fond «Podsolnuh». (2020). Chto takoe pervichnyiy immunodefitsit? URL: https://www.fondpodsolnuh.ru/disease/article.xl?id=28967.

MOZ Ukrainy. (2015). Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy. Zahalnyi variabelnyi (pervynnyi) imunodefitsyt. Nakaz MOZ Ukrainy vid 20.01.2015 No. 22. URL: https://dec.gov.ua/wp-content/uploads/images/dodatki/2015_22_ZVID/2015_22_YKPMD_ZVID.pdf.

Chernysheva LI, Bondarenko AV, Volokha AP ta in. (2013). Khronichnyi shkirno-slyzovyi kandydoz yak pervynnyi imunodefitsyt u ditei. Zdorove rebenka. 2 (45): 112—119.

Chernysheva LI, Bondarenko AV, Kostiuchenko LV ta in. (2015). Epidemiolohiia pervynnykh v Ukraini za danymy reiestru patsiientiv. Zdorove rebenka. 7 (67): 16—22.

Shklyarska O. (2018). «Ohmatdet»: spasut li ukrainskih detey inostrannyie vrachi? Racurs.ua. 05.10.2018.

Al-Herz W, Bousfiha A, Casanova J-L et al. (2011). Primary immunodeficiency diseases: an update on the classification from the International Unit of Immunological Societies Expert Committee for Primary Immunodeficiency. Frontiers in Immunology. 2 (54): 1—26.

Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, AlHerz W, Chatila T, Crow YJ, Cunningham-Rundles C, Etzioni A, Luis J. (2018). J Clin Immunol. 38 (1): 129—143. Published online 2017 Dec 11 https://doi.org/10.1007/s10875-017-0465-8; PMid:29226301 PMCid:PMC5742599.

Chapel H, Prevot J, Gaspar H, Espanol T, Bonilla F, Solis L, Drabwell J. (2014). Primary immune deficiencies – principles of care. Online 2014, Dec 15. https://doi.org/10.3389/fimmu.2014.00627.

Chen X, Xu Q, Li X et al. (2019). Cite as Molecular and Phenotypic Characterization of Nine Patients with STAT1 GOF Mutations in China. First Online: 04 November 2019. Journal of Clinical Immunology: 1—14. https://doi.org/10.1007/s10875-019-00688-3; PMid:31686315

Hori T, Ohnishi H, Teramoto T, Tsubouchi K, Naiki T, Hirose Y et al. (2012). Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism. J Clin Immunol. 32: 1213—1220. https://doi.org/10.1007/s10875-012-9744-6; PMid:22847544.

Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A et al. (2011). Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 208: 1635-1648. https://doi.org/10.1084/jem.20110958; PMid:21727188 PMCid:PMC3149226.

Picard C, Gaspar HB, Al–Herz W, Bousfiha A, Chatila T, Crow YJ et al. (2017). International Union of Immunological Societies. Primary Immunodeficiency Diseases Committee report on inborn errors of immunity. J Clin Immunol (in Press). https://doi.org/10.1007/s10875-017-0464-9; PMid:29226302 PMCid:PMC5742601

Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK et al. (2011). Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 332: 65—68. https://doi.org/10.1126/science.1200439; PMid:21350122 PMCid:PMC3070042.

Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL. (2012). Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 12: 616—622. https://doi.org/10.1097/ACI.0b013e328358cc0b; PMid:23026768 PMCid:PMC3538358.

Takezaki S, Yamada M, Kato M, Park MJ, Maruyama M, Yamazaki Y, Chida N, Ohara O, Kobayashi I, Ariga T. (2012). Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain. J. Immunol. 189: 1521—1526. https://doi.org/10.4049/jimmunol.1200926; PMid:22730530

Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C et al. (2011). STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 365: 54—61. https://doi.org/10.1056/NEJMoa1100102; PMid:21714643.

Yamazaki Y, Yamada M, Kawai T, Morio T, Onodera M, Ueki M, Watanabe N, Takada H, Takezaki S, Chida N, Kobayashi I and Ariga T. (2014). Two Novel Gain-of-Function Mutations of STAT1 Responsible for Chronic Mucocutaneous Candidiasis Disease: Impaired Production of IL-17A and IL-22, and the Presence of Anti-IL-17F Autoantibody. J Immunol November. 193 (10): 4880—4887. https://doi.org/10.4049/jimmunol.1401467; PMid:25288569.

Published

2020-06-29